217 related articles for article (PubMed ID: 29329518)
21. Gemcitabine-induced thrombotic microangiopathy treated with eculizumab: a case report.
Van den Eeckhaut L; Hannon H; Schurgers M; Monsaert E; Claes K
J Gastrointest Oncol; 2022 Dec; 13(6):3314-3320. PubMed ID: 36636054
[TBL] [Abstract][Full Text] [Related]
22. Eculizumab for drug-induced de novo posttransplantation thrombotic microangiopathy: A case report.
Safa K; Logan MS; Batal I; Gabardi S; Rennke HG; Abdi R
Clin Nephrol; 2015 Feb; 83(2):125-9. PubMed ID: 24495904
[TBL] [Abstract][Full Text] [Related]
23. Role of eculizumab in a pediatric refractory gemcitabine-induced thrombotic microangiopathy: a case report.
Facchini L; Lucchesi M; Stival A; Roperto RM; Melosi F; Materassi M; Farina S; Tintori V; de Martino M; Sardi I
J Med Case Rep; 2017 Jul; 11(1):209. PubMed ID: 28747219
[TBL] [Abstract][Full Text] [Related]
24. Eculizumab in the management of drug-induced thrombotic microangiopathy: A scoping review of the literature.
Zafar A; Lim MY; Abou-Ismail MY
Thromb Res; 2023 Apr; 224():73-79. PubMed ID: 36871347
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy of eculizumab in a case of pregnancy-associated aHUS].
Cravero R; Ardissino G; Colageo U; Staffa P; Bruschetta E; Maroni S; Karvela E; Spagarino E; Ruggeri V; Jura R
G Ital Nefrol; 2016; 33(4):. PubMed ID: 27545639
[TBL] [Abstract][Full Text] [Related]
26. Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases.
Fakhouri F; Delmas Y; Provot F; Barbet C; Karras A; Makdassi R; Courivaud C; Rifard K; Servais A; Allard C; Besson V; Cousin M; Châtelet V; Goujon JM; Coindre JP; Laurent G; Loirat C; Frémeaux-Bacchi V
Am J Kidney Dis; 2014 Jan; 63(1):40-8. PubMed ID: 24021908
[TBL] [Abstract][Full Text] [Related]
27. Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome.
Cugno M; Gualtierotti R; Possenti I; Testa S; Tel F; Griffini S; Grovetti E; Tedeschi S; Salardi S; Cresseri D; Messa P; Ardissino G
J Thromb Haemost; 2014 Sep; 12(9):1440-8. PubMed ID: 24853860
[TBL] [Abstract][Full Text] [Related]
28. Gemcitabine-induced thrombotic microangiopathy with nephrotic syndrome.
Katagiri D; Hinoshita F
CEN Case Rep; 2018 Nov; 7(2):217-220. PubMed ID: 29766468
[TBL] [Abstract][Full Text] [Related]
29. Thrombotic microangiopathy after kidney transplantation: Analysis of the Brazilian Atypical Hemolytic Uremic Syndrome cohort.
Nga HS; Palma LMP; Ernandes Neto M; Fernandes-Charpiot IMM; Garcia VD; Kist R; Miranda SMC; Macedo de Souza PA; Pereira GM; de Andrade LGM
PLoS One; 2021; 16(11):e0258319. PubMed ID: 34748552
[TBL] [Abstract][Full Text] [Related]
30. A Case Report of Quinine-Induced Thrombotic Microangiopathy Successfully Treated With Eculizumab.
Ng JY; Lenton D; Kerridge I; Wong C
J Investig Med High Impact Case Rep; 2024; 12():23247096241235617. PubMed ID: 38477293
[TBL] [Abstract][Full Text] [Related]
31. A Rare Case of Lupus Nephritis Presenting as Thrombotic Microangiopathy with Diffuse Pseudotubulization Possibly Caused by Atypical Hemolytic Uremic Syndrome.
Ono M; Ohashi N; Namikawa A; Katahashi N; Ishigaki S; Tsuji N; Isobe S; Iwakura T; Sakao Y; Tsuji T; Kato A; Fujigaki Y; Shimizu A; Yasuda H
Intern Med; 2018 Jun; 57(11):1617-1623. PubMed ID: 29434134
[TBL] [Abstract][Full Text] [Related]
32. Gemcitabine-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Held-Warmkessel J
Oncol Nurs Forum; 2014 Sep; 41(5):551-3. PubMed ID: 25158661
[TBL] [Abstract][Full Text] [Related]
33. Thrombotic microangiopathy in a sirolimus-treated renal transplant patient receiving gemcitabine for lung cancer.
Courtellemont C; Guitard J; Mehrenberger M; Pontier S; Ribes D; Kamar N; Esposito L; Modesto A; Rostaing L
Clin Nephrol; 2007 Feb; 67(2):114-8. PubMed ID: 17338432
[TBL] [Abstract][Full Text] [Related]
34. Complement Inhibitors in the Management of Complement-Mediated Hemolytic Uremic Syndrome and Paroxysmal Nocturnal Hemoglobinuria.
Begum F; Khan N; Boisclair S; Malieckal DA; Chitty D
Am J Ther; 2023 May; 30(3):e209-e219. PubMed ID: 37104648
[TBL] [Abstract][Full Text] [Related]
35. Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation.
Hadaya K; Ferrari-Lacraz S; Fumeaux D; Boehlen F; Toso C; Moll S; Martin PY; Villard J
Am J Transplant; 2011 Nov; 11(11):2523-7. PubMed ID: 21831149
[TBL] [Abstract][Full Text] [Related]
36. Complement-mediated thrombotic microangiopathy treated with anticomplement protein 5 therapy, a retrospective study.
Laber DA; Patel PC; Logothetis CN; Patel AK; Jaglal M; Haider M; Visweshwar N; Rajasekaran-Rathnakumar G; Eatrides J
Eur J Haematol; 2024 Mar; 112(3):450-457. PubMed ID: 37984551
[TBL] [Abstract][Full Text] [Related]
37. Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study.
Menne J; Delmas Y; Fakhouri F; Licht C; Lommelé Å; Minetti EE; Provôt F; Rondeau E; Sheerin NS; Wang J; Weekers LE; Greenbaum LA
BMC Nephrol; 2019 Apr; 20(1):125. PubMed ID: 30971227
[TBL] [Abstract][Full Text] [Related]
38. [Thrombotic microangiopathy under an effective treatment with gemcitabine].
Finkenwirth P; Schick D; Horger MS; Fend F; Lauer UM; Gregor M; Bitzer M
Z Gastroenterol; 2009 Mar; 47(3):288-91. PubMed ID: 19280543
[TBL] [Abstract][Full Text] [Related]
39. Two cases of carfilzomib-induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma.
Rassner M; Baur R; Wäsch R; Schiffer M; Schneider J; Mackensen A; Engelhardt M
BMC Nephrol; 2021 Jan; 22(1):32. PubMed ID: 33461512
[TBL] [Abstract][Full Text] [Related]
40. Complement activation and blockade in massive post-partum haemorrhage, thrombotic microangiopathy and acute kidney injury: a case report.
Guzzo G; Kissling S; Pantaleo G; Pascual M; Sadallah S; Teta D
BMC Nephrol; 2021 Jul; 22(1):252. PubMed ID: 34229609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
